Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Summa Health

Hospital system no longer accepting radiology patients with out-of-network health plans

Summa Health said the change will take effect Sept. 1, with the two-hospital network ceasing scheduling of appointments for this consumer segment.

FDA announces recall of Boston Scientific interventional radiology devices, citing risk of serious injury or death

Its alert pertains to over 26K carotid artery stents, used by interventional neuroradiologists, vascular surgeons and other docs to prevent strokes. 

Akumin

Radiology provider Akumin touts launch of its first movable PET/CT imaging centers

The Plantation, Florida, company first announced the initiative at RSNA 2024, offering clients new “relocatable and expandable” centers to be deployed across the U.S. 

Solis Mammography

Private equity-backed Solis Mammography opens 3 new locations

The breast imaging group is launching two locations in Texas and marking its first foray into the Raleigh metro area, with more on the way in North Carolina. 

AI patient portal messages personalized care

Healthcare AI today: $81M acquisition, Illinois says no to AI therapy, AI glucose cleared, more

FDA clears AI-powered glucose monitoring app. The clearance marks a first for an over-the-counter tool in this category.

surgery value quality pre-op

Data policy research: AI hesitancy remains real, and value-based care models are still an uncertainty

Tech vendor Reveleer and policy analytics firm Mathematica released their 2025 State of Technology in Value-Based Care report, the findings of which show that AI adoption in healthcare is widespread—but integration is spotty. 

warning safety alert recall healthcare issue

AI-enabled devices lacking validation data prior to FDA clearance more likely to be recalled

FDA 510(k) clearance does not require that AI devices are subject to prospective human studies prior to approval.

The Abbott Esprit BTK everolimus-eluting biosorbable scaffold system for below the knee peripheral artery disease on display at TCT 2024. Photo by Dave FornellTCTn 2024 DF

Abbott’s dissolving stent picks up a key approval

It's another big victory for Abbott's bioresorbable stent for BTK PAD. 

Displaying 313 - 320 of 15367
Design by Adaptive Theme